Cerevel Therapeutics HoldingCERE
13F holders, Q3 2024 (September 30)2holders −229
0new positions
228sold out
$43.83avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Cerevel Therapeutics Holding (CERE) in their 13F filings, down 229 from Q2 2024. 0 opened new positions and 228 sold out. The largest holders were IFP Advisors, Inc ($16K) and Blue Trust, Inc. ($5K).
- Company
- Cerevel Therapeutics Holding
- CUSIP
- 15678U128
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 228 | $6.3B |
All 13F filers, Q2 2024 → Q3 2024: 7 shares bought and 153,360,008 shares sold, net −153,360,001 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| IFP Advisors, Inc | 0.00% | Reduce -54.7% | 346 | $16K |
| Blue Trust, Inc. | 0.00% | Add +5.9% | 126 | $5K |
"% of holder's portfolio" is CERE's weight in each manager's 13F, not the share of Cerevel Therapeutics Holding the manager owns.